EUVIMEDEUVIMED entdecken
Crossref

Exploitation of a novel adjuvant for polymyxin B against multidrug-resistant Acinetobacter baumannii

Seon-Yeong Kim, Hwi Won Seo, Min-Seon Park, Chul Min Park, Jinho Seo, Jaerang Rho, Subeen Myung, Kwan Soo Ko iD, Jun-Seob Kim iD, Choong-Min Ryu iD

Journal of Antimicrobial Chemotherapy · 2023

DOI: 10.1093/jac/dkac445 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2023. Verfasst von Seon-Yeong Kim und 9 weiteren Autor:innen. Beteiligte Einrichtung: Infection Disease Research Center, KRIBB, Daejeon 34141, South Korea. Hauptthemen laut MEDLINE: Polymyxin B, Acinetobacter baumannii. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: National Research Foundation of Korea, NRF, Korean government.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Although polymyxin has been used as a last-resort antibiotic against resistant bacteria, its use is restricted due to nephrotoxicity and neurotoxicity. While the present antibiotic resistance issue compels clinicians to reconsider polymyxin use in severe illness cases, polymyxin-resistant microorganisms exert an effect.

Objectives

To address the issue of antibiotic resistance, the cycle of developing new antibiotics to counteract emerging resistance must be discontinued. Here we tried to develop novel therapies that do not rely on direct antimicrobial activity and thus do not promote antibiotic resistance.

Methods

By a high-throughout screening system based on bacterial respiration, chemical compounds accelerating the antimicrobial effects of polymyxin B were screened. In vitro and in vivo tests were performed to validate adjuvanticity. In addition, membrane depolarization and total transcriptome analysis were used to determine molecular mechanisms.

Results

PA108, a newly discovered chemical compound, was used to eradicate polymyxin-resistant A. baumannii and three other species in the presence of polymyxin B at concentrations less than the MIC. Since this molecule lacks self-bactericidal action, we hypothesized that PA108 acts as an antibiotic adjuvant, enhancing the antimicrobial activity of polymyxin B against resistant bacteria. At working concentrations, no toxicity was observed in cell lines or mice, although co-treatment with PA108 and polymyxin B increased survival of infected mouse and decreased bacterial loads in organs.

Conclusions

Boosting antibiotic efficiency through the use of antibiotic adjuvants holds significant promise for tackling the rise in bacterial antibiotic resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polymyxin BAcinetobacter baumanniiAnimalsMiceDrug Resistance, Multiple, BacterialAnti-Bacterial AgentsPolymyxinsMicrobial Sensitivity Tests

Substanzen

Polymyxin BAnti-Bacterial AgentsPolymyxins

Autor:innen und Institutionen

  • Infection Disease Research Center, KRIBB, Daejeon 34141, South Korea.
  • Department of Microbiology and Molecular Biology, Chungnam National University, Daejeon 34134, South Korea.
  • Department of Infectious Diseases Research, Korea Research Institute of Chemical Technology Daejeon 34114, South Korea.
  • Medicinal Chemistry and Pharmacology, Korea University of Science and Technology, Daejeon 34114, South Korea.
  • Environental Disease Research Center, KRIBB, Daejeon 34141, South Korea.
  • Department of Microbiology, Sungkyunkwan University School of Medicine, Suwon 16419, South Korea.

ORCID-Profile: Kwan Soo Ko, Jun-Seob Kim, Choong-Min Ryu

Förderung

  • National Research Foundation of Korea
  • NRF
  • Korean government
  • MSIT
  • MIST

Zitieren

APA

Kim, S. Y., Seo, H. W., Park, M. S., Park, C. M., Seo, J., Rho, J., Myung, S., Ko, K. S., Kim, J. S., & Ryu, C. M. (2023). Exploitation of a novel adjuvant for polymyxin B against multidrug-resistant Acinetobacter baumannii. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkac445

Vancouver

Kim SY, Seo HW, Park MS, Park CM, Seo J, Rho J, et al. Exploitation of a novel adjuvant for polymyxin B against multidrug-resistant Acinetobacter baumannii. Journal of Antimicrobial Chemotherapy. 2023. doi:10.1093/jac/dkac445

BibTeX
@article{Kim2023,
  author = {Kim, Seon-Yeong and Seo, Hwi Won and Park, Min-Seon and Park, Chul Min and Seo, Jinho and Rho, Jaerang and Myung, Subeen and Ko, Kwan Soo and Kim, Jun-Seob and Ryu, Choong-Min},
  title = {Exploitation of a novel adjuvant for polymyxin B against multidrug-resistant Acinetobacter baumannii},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2023},
  doi = {10.1093/jac/dkac445}
}
Kostenlos starten →